摘要:
The present invention provides a compound of formula I and the use thereof for the inhibition of bacterial cell wall biosynthesis and for the therapeutic treatment of bacterial infection or disease in a patient in need thereof. The present invention also provides the use of the formula I compound for the control of ecto- or endoparasites in homeothermic animals.
摘要:
The present invention provides a compound of formula I and the use thereof for the inhibition of bacterial cell wall biosynthesis and for the therapeutic treatment of bacterial infection or disease in a patient in need thereof. The present invention also provides the use of the formula I compound for the control of ecto- or endoparasites in homeothermic animals.
摘要:
The present invention provides a compound of formula I and the use thereof for the inhibition of bacterial cell wall biosynthesis and for the therapeutic treatment of bacterial infection or disease in a patient in need thereof. The present invention also provides the use of the formula I compound for the control of ecto- or endoparasites in homeothermic animals
摘要:
The present invention provides compounds and methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.
摘要:
The present invention provides compounds and methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.
摘要:
The present invention provides a 2-amino-5-[substituted-4-(difluoromethoxy)phenyl]-5-phenylimidazolone compound of formula I The present invention also provides methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.
摘要:
The present invention provides compounds and methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.
摘要:
Compounds useful for lowering beta amyloid levels are provided. The compounds have the structure of formula Ia: wherein, R1 is lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, or SO2R5; R5 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, or substituted alkyl; R2 is lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, or cycloalkyl; R3 is hydrogen, lower alkyl, or substituted lower alkyl; R4 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, thiophene, or substituted thiophene; R6 is hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, or substituted cycloalkyl; W, X and Y are independently CR7 or N; and R7 is hydrogen, halogen, lower alkyl, or substituted lower alkyl.
摘要翻译:提供了可用于降低β淀粉样蛋白水平的化合物。 化合物具有式Ia的结构:其中R 1是低级烷基,取代的低级烷基,苯基,取代的苯基,苄基,取代的苄基,苄氧基,取代的苄氧基或SO 2, / 5> 5 R 5是苯基,取代的苯基,杂环,取代的杂环,烷基或取代的烷基; R 2是低级烷基,取代的低级烷基,CF 3,烯基,取代的烯基,炔基,取代的炔基,苯基,取代的苯基或环烷基; R 3是氢,低级烷基或取代的低级烷基; R 4是苯基,取代的苯基,杂环,取代的杂环,噻吩或取代的噻吩; R 6是氢,低级烷基,取代的低级烷基,CF 3,烯基,取代的烯基,炔基,取代的炔基,苯基,取代的苯基,环烷基或取代的环烷基; W,X和Y独立地为CR 7或N; R 7是氢,卤素,低级烷基或取代的低级烷基。
摘要:
Compounds useful for lowering beta amyloid levels are provided. The compounds have the structure of formula Ia: wherein, R1 is lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, or SO2R5; R5 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, or substituted alkyl; R2 is lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, or cycloalkyl; R3 is hydrogen, lower alkyl, or substituted lower alkyl; R4 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, thiophene, or substituted thiophene; R6 is hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, or substituted cycloalkyl; W, X and Y are independently CR7 or N; and R7 is hydrogen, halogen, lower alkyl, or substituted lower alkyl.
摘要翻译:提供了可用于降低β淀粉样蛋白水平的化合物。 所述化合物具有式Ia的结构:其中,R 1为低级烷基,取代的低级烷基,苯基,取代的苯基,苄基,取代的苄基,苄氧基,取代的苄氧基或SO 2 R 5; R5是苯基,取代的苯基,杂环,取代的杂环,烷基或取代的烷基; R2是低级烷基,取代的低级烷基,CF3,烯基,取代的烯基,炔基,取代的炔基,苯基,取代的苯基或环烷基; R3是氢,低级烷基或取代的低级烷基; R4是苯基,取代的苯基,杂环,取代的杂环,噻吩或取代的噻吩; R 6是氢,低级烷基,取代的低级烷基,CF 3,烯基,取代的烯基,炔基,取代的炔基,苯基,取代的苯基,环烷基或取代的环烷基; W,X和Y独立地为CR 7或N; 并且R 7是氢,卤素,低级烷基或取代的低级烷基。
摘要:
Compounds useful for lowering beta amyloid levels are provided. The compounds have the structure of formula Ia: wherein, R1 is lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, or SO2R5; R5 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, or substituted alkyl; R2 is lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, or cycloalkyl; R3 is hydrogen, lower alkyl, or substituted lower alkyl; R4 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, thiophene, or substituted thiophene; R6 is hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, or substituted cycloalkyl; W, X and Y are independently CR7 or N; and R7 is hydrogen, halogen, lower alkyl, or substituted lower alkyl.
摘要翻译:提供了可用于降低β淀粉样蛋白水平的化合物。 所述化合物具有式Ia的结构:其中,R 1为低级烷基,取代的低级烷基,苯基,取代的苯基,苄基,取代的苄基,苄氧基,取代的苄氧基或SO 2 R 5; R5是苯基,取代的苯基,杂环,取代的杂环,烷基或取代的烷基; R2是低级烷基,取代的低级烷基,CF3,烯基,取代的烯基,炔基,取代的炔基,苯基,取代的苯基或环烷基; R3是氢,低级烷基或取代的低级烷基; R4是苯基,取代的苯基,杂环,取代的杂环,噻吩或取代的噻吩; R 6是氢,低级烷基,取代的低级烷基,CF 3,烯基,取代的烯基,炔基,取代的炔基,苯基,取代的苯基,环烷基或取代的环烷基; W,X和Y独立地为CR 7或N; 并且R 7是氢,卤素,低级烷基或取代的低级烷基。